Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

Detalles Bibliográficos
Autores principales: Teich, Katrin, Krzykalla, Julia, Kapp-Schwoerer, Silke, Gaidzik, Verena I., Schlenk, Richard F., Paschka, Peter, Weber, Daniela, Fiedler, Walter, Kühn, Michael W. M., Schroeder, Thomas, Mayer, Karin, Lübbert, Michael, Ramachandran, Dhanya, Benner, Axel, Ganser, Arnold, Döhner, Hartmut, Heuser, Michael, Döhner, Konstanze, Thol, Felicitas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561276/
https://www.ncbi.nlm.nih.gov/pubmed/34047179
http://dx.doi.org/10.3324/haematol.2021.278894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561276/
https://www.ncbi.nlm.nih.gov/pubmed/34047179
http://dx.doi.org/10.3324/haematol.2021.278894

Ejemplares similares